美年健康收盘上涨1.19%，滚动市盈率68.15倍，总市值200.02亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Meinian Health, indicating a significant premium in its price-to-earnings (PE) ratio compared to the industry average [1][2] - As of June 26, Meinian Health's closing price was 5.11 yuan, with a PE ratio of 68.15, significantly higher than the industry average of 39.58 [1][2] - The total market capitalization of Meinian Health is reported at 20.002 billion yuan [1][2] Group 2 - In the first quarter of 2025, Meinian Health reported an operating revenue of 1.754 billion yuan, reflecting a year-on-year decrease of 2.62% [1] - The net profit for the same period was reported as a loss of approximately 275.34 million yuan, with a year-on-year increase of 3.94% [1] - The gross profit margin for Meinian Health stands at 24.04% [1] Group 3 - As of the first quarter of 2025, a total of 50 institutions hold shares in Meinian Health, including 42 funds and 8 other entities, with a total shareholding of approximately 1.6629 billion shares valued at 9.379 billion yuan [1]